NGL Fine-Chem Limited (NSE:NGLFINE)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Human and Veterinary Active Pharmaceutical Ingredients	3.34B
Human and Veterinary Active Pharmaceutical Ingredients Growth	21.98%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Asia Pacific	980.01M
Asia Pacific Growth	5.67%
Rest of the World	797.74M
Rest of the World Growth	133.36%
India	792.74M
India Growth	31.46%
Europe	704.59M
Europe Growth	-12.84%
United States	62.03M
United States Growth	12.62%